SPTLC2
Basic information
Region (hg38): 14:77505997-77616637
Links
Phenotypes
GenCC
Source:
- neuropathy, hereditary sensory and autonomic, type 1C (Strong), mode of inheritance: AD
- hereditary sensory and autonomic neuropathy type 1 (Supportive), mode of inheritance: AD
- neuropathy, hereditary sensory and autonomic, type 1C (Strong), mode of inheritance: AD
- neuropathy, hereditary sensory and autonomic, type 1C (Strong), mode of inheritance: AD
- neuropathy, hereditary sensory and autonomic, type 1C (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neuropathy, hereditary sensory and autonomic, type IC | AD | Neurologic | The condition involves sensory neuropathy with variable autonomic and motor involvement, and medical management (eg, with oral serine supplementation) has been reported as resulting in laboratory-based and clinical benefits | Neurologic | 20920666; 23658386; 26681808; 30626650; 30866134; 30955194 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPTLC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 93 | 98 | ||||
missense | 198 | 213 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 16 | 12 | 1 | 29 | ||
non coding | 72 | 48 | 107 | 227 | ||
Total | 1 | 4 | 284 | 150 | 114 |
Variants in SPTLC2
This is a list of pathogenic ClinVar variants found in the SPTLC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-77506031-A-G | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506115-C-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77506204-G-C | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 12, 2018) | ||
14-77506216-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77506266-T-G | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77506294-A-AT | Neuropathy, hereditary sensory and autonomic, type 1C | Likely benign (Jun 14, 2016) | ||
14-77506369-A-G | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77506392-G-T | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506432-T-C | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77506485-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506753-T-C | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506774-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77506889-G-C | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506926-A-G | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77506927-T-C | Neuropathy, hereditary sensory and autonomic, type 1C | Conflicting classifications of pathogenicity (Aug 01, 2022) | ||
14-77506981-T-C | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77507252-A-T | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77507276-C-T | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77507334-T-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77507336-T-G | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77507370-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Jan 13, 2018) | ||
14-77507442-T-G | Neuropathy, hereditary sensory and autonomic, type 1C | Benign (Mar 06, 2018) | ||
14-77507459-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) | ||
14-77507529-G-A | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 13, 2018) | ||
14-77507602-G-T | Neuropathy, hereditary sensory and autonomic, type 1C | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPTLC2 | protein_coding | protein_coding | ENST00000216484 | 12 | 110777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.780 | 0.220 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.04 | 210 | 311 | 0.675 | 0.0000172 | 3642 |
Missense in Polyphen | 31 | 76.851 | 0.40338 | 908 | ||
Synonymous | -0.632 | 123 | 114 | 1.08 | 0.00000633 | 1110 |
Loss of Function | 3.92 | 5 | 27.0 | 0.185 | 0.00000141 | 353 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000528 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate. {ECO:0000269|PubMed:19416851, ECO:0000269|PubMed:20920666}.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Sphingolipid Metabolism;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;ceramide <i>de novo</i> biosynthesis;Sphingolipid de novo biosynthesis;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.200
Intolerance Scores
- loftool
- 0.0980
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.264
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.500
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sptlc2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sphingomyelin biosynthetic process;sphingolipid biosynthetic process;sphinganine biosynthetic process;sphingosine biosynthetic process;ceramide biosynthetic process;positive regulation of lipophagy
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane;serine C-palmitoyltransferase complex
- Molecular function
- serine C-palmitoyltransferase activity;pyridoxal phosphate binding